DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Phase 1

Active, not recruiting

Conditions: Head and Neck Neoplasms
Squamous Cell Carcinoma of Head and Neck
Head and Neck Cancer

Interventions: Drug: Xevinapant
Drug: Carboplatin
Drug: Paclitaxel
Radiation: Radiation Therapy

First Posted Date: 2023-10-31

Last Posted Date: 2024-06-04

Lead Sponsor: University of Chicago

Target Recruit Count: 42

Registration Number: NCT06110195

Locations: 🇺🇸
University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Virtual Diabetes Group Visits Across Health Systems

Phase 2

Recruiting

Conditions: Obesity
Stroke
T2DM (Type 2 Diabetes Mellitus)
Hypertension
Hyperlipidemias
Peripheral Vascular Diseases
Heart Disease Chronic

Interventions: Behavioral: Virtual Group Visit

First Posted Date: 2023-10-23

Last Posted Date: 2025-04-06

Lead Sponsor: University of Chicago

Target Recruit Count: 720

Registration Number: NCT06094491

Locations: 🇺🇸
Access Community Health Network, Chicago, Illinois, United States
🇺🇸
Advocate Health Care, Orland Park, Illinois, United States

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Not Applicable

Recruiting

Conditions: Hemorrhagic Stroke
Stroke, Acute
Ischemic Stroke, Acute

Interventions: Behavioral: HI-SPEED Protocol

First Posted Date: 2023-10-23

Last Posted Date: 2025-04-06

Lead Sponsor: University of Chicago

Target Recruit Count: 900

Registration Number: NCT06094478

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
New York Presbyterian - Weill Cornell Hospital, New York, New York, United States
🇺🇸
University of Utah Health, Salt Lake City, Utah, United States

and more 2 locations

A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans

Not Applicable

Recruiting

Conditions: Blood Pressure
Hypertension

Interventions: Other: USeeBP

First Posted Date: 2023-10-12

Last Posted Date: 2025-02-27

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT06078540

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone

Early Phase 1

Recruiting

Conditions: Atrial Fibrillation
Post-Op Complication

Interventions: Combination Product: CardiaMend in Combination with Amiodarone

First Posted Date: 2023-10-02

Last Posted Date: 2025-01-31

Lead Sponsor: University of Chicago

Target Recruit Count: 63

Registration Number: NCT06063538

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection

Phase 4

Recruiting

Conditions: COVID-19

First Posted Date: 2023-08-24

Last Posted Date: 2025-01-13

Lead Sponsor: University of Chicago

Target Recruit Count: 280

Registration Number: NCT06008860

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

Phase 1

Recruiting

Conditions: HPV-Negative Squamous Cell Carcinoma

Interventions: Radiation: Low Dose Radiation
Radiation: Standard Dose Radiation
Drug: Paclitaxel
Drug: Carboplatin
Drug: Cisplatin
Drug: TFHX Regimen
Drug: Cetuximab

First Posted Date: 2023-08-22

Last Posted Date: 2024-05-17

Lead Sponsor: University of Chicago

Target Recruit Count: 36

Registration Number: NCT06005324

Locations: 🇺🇸
University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

Recruiting

Conditions: Acute Kidney Injury
Biomarkers

Interventions: Device: ESTOP - AKI 2.0

First Posted Date: 2023-08-14

Last Posted Date: 2024-08-09

Lead Sponsor: University of Chicago

Target Recruit Count: 800

Registration Number: NCT05988658

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸
University of Wisconsin Hospital, Madison, Wisconsin, United States

A Study of Glutathione in Children With Autism Spectrum Disorder

Phase 4

Terminated

Conditions: Autism Spectrum Disorder

Interventions: Drug: Glutathione

First Posted Date: 2023-07-20

Last Posted Date: 2023-08-23

Lead Sponsor: University of Chicago

Target Recruit Count: 6

Registration Number: NCT05954052

Locations: 🇺🇸
The University of Chicago Medicine, Chicago, Illinois, United States

Prosocial Effects of MDMA

Early Phase 1

Completed

Conditions: MDMA ('Ecstasy')
Social Interaction

Interventions: Drug: MDMA
Drug: Placebo

First Posted Date: 2023-07-17

Last Posted Date: 2024-08-19

Lead Sponsor: University of Chicago

Target Recruit Count: 33

Registration Number: NCT05948683

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy